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Seyedhossein Aharinejad, Marina Camera, Elena Tremoli, Alberto Corsini
Objective—Integrin-mediated cell adhesion to type I fibrillar collagen regulates gene and protein expression, whereas little
is known of its effect on lipid metabolism. In the present study, we examined the effect of type I fibrillar collagen on
cholesterol biosynthesis in human aortic smooth muscle cells (SMCs).
Methods and Results—SMCs were cultured on either fibrillar or monomer collagen for 48 hours and [14C]-acetate
incorporation into cholesterol was evaluated. Fibrillar collagen reduced by 72.92.6% cholesterol biosynthesis without
affecting cellular cholesterol levels. Fibrillar collagen also reduced 3-hydroxy-3-methylglutaryl coenzyme A reductase
(HMG-CoA) promoter activity (72.67.3%), mRNA (58.76.4%), protein levels (35.58.5%), and enzyme
activity (37.72.2%). Intracellular levels of the active form of sterol regulatory element binding proteins (SREBP)
1a was decreased by 60.721.7% in SMCs cultured on fibrillar collagen, whereas SREBP2 was not significantly
affected (12.17.1%). The overexpression of the active form of SREBP1a rescued the downregulation of fibrillar
collagen on HMG-CoA reductase levels. Blocking antibody to 2 integrin partially reversed the downregulation of
HMG-CoA reductase mRNA expression. Finally, fibrillar collagen led to an intracellular accumulation of
unprenylated Ras.
Conclusions—Our study demonstrated that 21 integrin interaction with fibrillar collagen affected the expression of
HMG-CoA reductase, which led to the inhibition of cholesterol biosynthesis in human SMCs. (Arterioscler Thromb
Vasc Biol. 2009;29:1631-1637.)
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Smooth muscle cells (SMCs) normally reside in the mediaof the artery surrounded by a meshwork of extracellular
matrix (ECM) components, including type I collagen. The
adhesion of SMCs to type I collagen is mainly mediated by
the interaction with 11 and 21 integrins that play a
pivotal role as a receptor for ECM. After their occupancy and
clustering, integrins can activate intracellular signaling path-
ways,1,2 followed by the induction of transcription factors,
and subsequent gene and protein expressions.3 Indeed, ECM
not only provides a scaffold for mechanical support and tissue
organization but also directly alters cell behavior by influ-
encing proliferation, migration, differentiation, and gene
expression.4,5 To resemble the extracellular environment
surrounding the SMCs present in the arterial wall, a cell
culture system based on 3 dimensional type I fibrillar colla-
gen gel has been developed.3,6 Cells cultured on fibrillar
collagen have been also compared to cells cultured on petri
dishes coated with monomeric collagen, a structural distinct
form of collagen that has been considered to resemble the
ECM environment surrounding SMCs in atherosclerotic
plaques.4,6,7 In this in vitro system, several changes have been
described, from inhibition of cell proliferation,7 migration,8,9
dedifferentiation,4 and ECM remodeling,6,8,10 supporting
the notion that cell– collagen interaction directly regulates
SMC function. Although these studies have helped to
understand the role of type I collagen on SMC behavior,
very little is known on its effect on cholesterol biosynthe-
sis and on mevalonate (MVA) pathway. On this matter it is
important to note that cholesterol present in the plasma
membrane lipid rafts has been shown to affect signal
transduction events initiated by cell adhesion to the ECM
trough integrins.11,12
Cholesterol represents one critical end-product of the
MVA pathway required for cell membrane formation in
proliferating cells.13 Moreover, MVA is not only the precur-
sor of cholesterol but also of a number of nonsteroidal
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isoprenoid moieties, including farnesyl-pyrophosphate (F-PP)
and geranylgeranyl-pyrophosphate (GG-PP).14 These 2 iso-
prenoid derivatives are indeed substrates of prenyltrans-
ferases that catalyze the prenylation of several intracellular
proteins, including the small GTP-binding protein Ras and
Ras-like proteins, such as Rho and Rac involved in several
cellular activities.3,15–18 Thus, the inhibition of the MVA
pathway may impair the activity of several intracellular
proteins, resulting in different cellular behavior. It is for this
reason that the MVA pathway and thus the cholesterol
biosynthesis are tightly regulated cellular events.19
Sterol regulatory element binding proteins (SREBPs),
bound to membranes of the endoplasmic reticulum (ER) and
nuclear envelope, play a pivotal role in the regulation of
cellular cholesterol content.20 The family consists of 3 differ-
ent proteins, SREBP1a, SREBP1c, and SREBP2. In cultured
cells, SREBP1a is expressed at much higher levels than
SREBP1c.21 The membrane associated proteins are transcrip-
tionally inactive and are bound to the SREBP-cleavage-
activating protein (SCAP), which functions as a sterol sen-
sor.22,23 When cells are deprived of sterols, SCAP escorts the
SREBPs from the ER to the Golgi, where a 2-step proteolytic
cleavage releases the amino terminus portion of the SREBPs
from cell membranes. These transcriptionally active frag-
ments of the SREBPs translocate to the nucleus activating the
transcription of genes involved in cholesterol biosynthesis
and in the MVA pathway.24,25
SREBP1a is a potent activator of all SREBP-responsive
genes, including those that mediate the biosynthesis of
cholesterol, fatty acids (FA), and triglycerides, but the roles
of SREBP1c and SREBP2 are more restricted.26 It is gener-
ally assumed that genes involved in FA metabolism (eg,
FA-synthase) are preferentially regulated by SREBP1c,
whereas the expression of enzymes involved in cholesterol
metabolism (eg, HMG-CoA synthase and reductase) and
uptake (LDL-receptor) are equally modulated by the activity
of both SREBP1c and SREBP2.26–28
In the present study we have investigated the effects of type
I fibrillar collagen on cholesterol metabolism in human aortic
SMCs. We show that fibrillar collagen, through 21 inte-
grin, has a profound effect on HMG-CoA reductase expres-
sion, event that altered cholesterol biosynthesis in human
aortic SMCs, without changing the intracellular cholesterol
content.
Experimental Procedures
Cell Culture and Collagen Matrix Preparation
Human aortic SMCs were isolated from the thoracic aorta of
cardiopathic patients undergoing cardiac transplantation. SMCs be-
tween passages 5 and 9 were cultured in 0.2% BSA/DMEM on the
surface of 3 dimensional fibrillar collagen gels (PureCol, Nutacon
BV, Leimuden, NE, 1.0 mg/mL final concentration) and monomer
collagen-coated dishes for 48 hours.7,29
For detailed descriptions of the Materials and Methods, ple-
ase see supplemental materials (available online at
http://atvb.ahajournals.org).
Results
Fibrillar Collagen Inhibits Cholesterol Biosynthesis
in Human SMCs
To study the effect of cell–collagen interaction on cholesterol
homeostasis we examined the effects of structurally distinct
forms of type I collagen, monomer versus polymerized
fibrils. All the experiments were performed under serum free
conditions, to induce cholesterol biosynthesis and to avoid
any confounding factors deriving from growth factors and
cytokines present in the FCS. Compared to monomer, fibrillar
collagen reduced cholesterol biosynthesis, measured by in-
corporation of [14C]-acetate into total cholesterol, by
72.92.6% (Figure 1A). In contrast, the total intracellular
cholesterol content was similar under the two experimental
conditions (Figure 1B).
HMG-CoA Reductase Activity Is Responsible for
the Reduction of Cholesterol Biosynthesis in
Human SMCs Cultured on Fibrillar Collagen£
To investigate the molecular mechanisms underling the
inhibition of cholesterol biosynthesis by fibrillar collagen,
we measured the HMG-CoA reductase activity, the rate
limiting step of the MVA pathway, under the aforemen-
tioned experimental conditions.13 The conversion of radio-
labeled HMG-CoA by isolated microsomes from human
SMCs cultured on fibrillar collagen to MVA was reduced
by 37.72.2% (Figure 2A). This effect strongly correlated
with the expression of HMG-CoA reductase measured by
Western blot analysis, which was decreased by 35.58.5%
(Figure 2B).
The expression of HMG-CoA reductase is primarily regu-
lated at the transcription levels,13 thus we measured the
mRNA levels and the promoter activities. As shown in Figure
2C, fibrillar collagen significantly reduced the mRNA of
HMG-CoA reductase by 58.76.4%, determined by quanti-
tative RT-PCR reaction. The analysis of the HMG-CoA
Figure 1. Fibrillar collagen inhibited cholesterol biosynthesis in
human SMCs. A, Human SMCs were cultured on monomer and
fibrillar collagen in DMEM containing 0.2% BSA in the presence
of [14C]-Acetate. After 48 hours [14C]-Acetate incorporation into
cellular cholesterol was evaluated. Each bar represents the
meanSD of triplicate dishes. *P0.01 fibrillar vs monomer col-
lagen (Student t test). The data are representative of 4 replicate
experiments. B, Under the same experimental conditions of A,
the total intracellular cholesterol content was evaluated by Gas
Chromatography. The data are representative of 2 replicate
experiments.
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reductase promoter activity by a luciferase assay also showed
a significant 72.67.3% reduction in human SMCs cultured
for 48 hours on fibrillar collagen, compared to monomer
(Figure 2D).
To directly demonstrate that the inhibition of cholesterol
biosynthesis elicited by fibrillar collagen was dependent by
the activity of the HMG-CoA reductase, we measured the
incorporation of radiolabeled MVA, the product of HMG-
CoA reductase reaction, into cellular cholesterol.13 As shown
in Figure 2E, the evaluation of cholesterol biosynthesis by
incubating SMCs with [14C]-acetate was strongly suppressed
by fibrillar collagen, whereas the incorporation of [3H]-MVA
was not affected.
Taken together, fibrillar collagen significantly affected
cholesterol biosynthesis by inhibiting the transcription and
therefore the activity of HMG-CoA reductase, the rate-
limiting step of the MVA pathway.
Fibrillar Collagen Regulates SREBP-1a
Transcriptional Activity
Several studies have firmly established the pivotal role of
SREBPs in the regulation of HMG-CoA reductase transcrip-
tion.13,28 To investigate whether the observed reduction of
HMG-CoA reductase expression levels mediated by fibrillar
collagen was dependent by the transcriptional activity of
SREBPs, we evaluated the processing and the expression of
SREBP1a and SREBP2. Western blotting analysis from total
cell lysates demonstrated that fibrillar collagen reduced the
expression levels of the active form of SREBP1a at 68 KDa
(60.721.7%) with a minor reduction of the pro form at
125 KDa (20.49.2%; Figure 3A). In contrast, the expres-
sion of the active form of SREBP2 was not dramatically
altered by fibrillar collagen compared to monomer
(12.17.1%) (Figure 3B). In addition, the incubation with
simvastatin induced both SREBP1a and SREBP2 processing
in both SMCs cultured on monomer and fibrillar collagen
(Figure 3A and 3B).
The expression of levels SREBP1a and SREBP2 mRNA
were also measured by RT-PCR from total RNA extracted
from SMCs cultured for 24 hours on monomer and fibrillar
collagen. Fibrillar collagen reduced by 48.329.4% the
expression level of SREBP1 mRNA, although this differ-
ence was found not to be statistically significant (Figure
3C), whereas SREBP2 expression levels were found sim-
ilar between monomer and fibrillar collagen (Figure 3D).
The incubation with simvastatin induced both genes in
SMCs cultured either on monomer or fibrillar collagen
(Figure 3C and 3D).
Figure 2. HMG-CoA reductase activity was suppressed in
human SMCs cultured on fibrillar collagen. A through E, Human
SMCs were cultured for 48 hours with DMEM containing 0.2%
BSA on monomer and fibrillar collagen. A, After this period, the
HMG-CoA reductase activity was determined by measuring the
rate of conversion of radioactive HMG-CoA into MVA in
detergent-solubilized cell-free extract as described in Material
and Methods. Each bar represents the meanSD of triplicate
samples. B, HMG-CoA reductase expression was evaluated by
Western blotting analysis of total protein extracts. Quantitative
densitometric analysis was performed with Gel Doc acquisition
system and Quantity One software (BIO-RAD). C, HMG-CoA
reductase mRNA expression was evaluated by quantitative real-
time polymerase chain reaction from total RNA. The data are
representative of 4 independent experiments. D, HMG-CoA pro-
moter activity was evaluated in human SMCs retrovirally
infected with pBM-SIN-HMG-CoApro-luciferase construct. The
data are representative of 2 independent experiments. E,
Human SMCs were cultured on monomer and fibrillar collagen
in DMEM containing 0.2% BSA in the presence of either [14C]-
Acetate or [3H]-MVA. After 48 hours [14C]-Acetate and [3H]-MVA
incorporation into cellular cholesterol was evaluated. Each bar
represents the meanSD of triplicate dishes. The data are rep-
resentative of 2 independent experiments. *P0.05; **P0.01
by Student t test.
Figure 3. Fibrillar collagen affected SREBP1a activation in
human SMCs. A through D, Human SMCs were cultured for
48 hours with DMEM containing 0.2% BSA on monomer and
fibrillar collagen. Two hours before preparation of protein
extracts 25 g/mL of the proteasome inhibitor ALLN was
added to the cultured media. SREBP1a and SREBP2 expres-
sion and processing were then evaluated by Western blotting
analysis of total protein extracts (A and B). As a positive con-
trol, cells were incubated with simvastatin (5 mol/L). For
SREBP1a precursor form the film was exposed for 10 min-
utes, whereas for SREBP1 active form for 2 minutes. C and
D, mRNA expression levels of SREBP1 and SREBP2 were
evaluated by quantitative real-time polymerase chain reaction
from total RNA extracted from SMCs cultured for 24 hours on
monomer and polymerized collagen.
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To further establish the effect of fibrillar collagen on
SREBP1a, we analyzed the mRNA levels of two genes
directly regulated by this transcription factor, such as
HMG-CoA synthase and FA-synthase.28 The expression
levels of HMG-CoA synthase and FA-synthase in SMCs
cultured on fibrillar collagen were reduced by 46.26.4%
and 67.316.0%, respectively, further supporting the effect
of fibrillar collagen on SREBP1a activity (supplemental
Figure I).
To directly demonstrate that SREBP1 transcriptional ac-
tivity was responsible for the reduction of HMG-CoA reduc-
tase in SMCs cultured on fibrillar collagen, we retrovirally
overexpressed in SMCs the active amino terminal portion of
SREBP1a. As shown in Figure 4, the overexpression of
SREBP1a in SMCs led to the upregulation of HMG-CoA
reductase mRNA (Figure 4A) and protein (Figure 4B) in
SMCs on either monomer or fibrillar collagen, compared to
cells transduced with empty vector control. Finally, the
downregulation of SREBP1 in human cultured SMCs by two
different siRNA probes significantly reduced the expression of
HMG-CoA reductase on both monomer and fibrillar collagen
(supplemental Figure II).
Taken together these results demonstrate that the inhibition
of HMG-CoA reductase transcription observed in human
SMCs cultured on fibrillar collagen is dependent by the
activity of SREBP1a.
21 Integrin Collagen Receptor Mediates the
Reduction of HMG-CoA Reductase Transcription
The adhesion of SMCs to fibrillar collagen is primarily
mediated by 11 and 21 integrin receptors.30 To inves-
tigate which of these two collagen receptors were responsible
for the observed responses, we first determine the effect of
blocking antibodies toward 1 and 2 integrin subunits on
SMC adhesion to fibrillar collagen. In agreement with
previous studies,31 the adhesion of human SMC to collagen
is largely mediated by 21 integrin, indeed the anti-2
blocking antibody reduced cell adhesion by 70.03.2%,
whereas anti-1 antibody affected only the 27.45.1%
(Figure 5A). Interestingly, the mRNA expression levels of
2 and 1 integrin subunits in SMCs cultured for 48 hours
on fibrillar collagen were increased by 8.9- and 8.7-fold,
respectively, whereas mRNA of 1 subunit was unaffected
(Figure 5B).
Incubation of human SMCs with blocking antibody to 2
integrin significantly prevented the effect of fibrillar collagen
on HMG-CoA reductase mRNA expression, whereas a block-
ing antibody directed to the 1 integrin subunit was ineffec-
tive (Figure 5C). These data indicate that the interaction of
SMCs with fibrillar collagen through 21 integrin partially
Figure 4. Overexpression of SREBP1a active form rescued the
effect of fibrillar collagen on the expression of HMG-CoA reduc-
tase. A and B, SMCs were transduced with pBM-IRES-PURO
retrovirus encoding control vector (PURO) or with SREBP1aNH2-
IRES-PURO encoding the active form of SREBP1 and then cul-
tured on monomer and fibrillar collagen for 48 hours in DMEM
containing 0.2% BSA. HMG-CoA reductase mRNA (A) and pro-
tein expression (B) were evaluated by quantitative real-time
polymerase chain reaction from total RNA and by Western blot-
ting analysis for total protein extracts, respectively.
Figure 5. Blocking antibody against 2 integrin abrogated the downregulation of HMG-CoA mRNA levels elicited by fibrillar collagen. A,
SMCs were incubated in suspension for 30 minutes with either 1 or 2 blocking antibody, and then the adhesion to fibrillar collagen
was measured as described in Materials and Methods. B, 1, 2, and 1 integrin subunit mRNA levels were determined from total
RNA isolated from human SMCs cultured for 48 hours in DMEM containing 0.2% BSA by GEArray Microarrays for Extracellular Matrix
& Adhesion Molecules Arrays (SABioscience) according to manufacturer’s instructions. C, Human SMCs were incubated in suspension
for 30 minutes with control IgG, anti-1, and anti-2 blocking antibody and then cultured on monomer and fibrillar collagen in DMEM
containing 0.2% BSA. After 48 hours HMG-CoA reductase mRNA levels were determined by quantitative real-time polymerase chain
reaction from total RNA. *P0.05; **P0.01; ***P0.001 fibrillar vs monomer collagen (Student t test). The data are representative of 3
independent experiments.
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mediates the downregulation of HMG-CoA reductase and
cholesterol biosynthesis.
Ras Farnesylation Is Partially Impaired in Human
SMCs Cultured on Fibrillar Collagen
Because the HMG-CoA reductase activity is the rate-limiting
step of the MVA pathway, the inhibition of its catalytic
activity in human SMCs could affect the biosynthesis of
isoprenoids involved in protein prenylation, such as F-PP and
GG-PP. Thus, to study whether fibrillar collagen can alter the
prenylation of intracellular proteins we determined, by West-
ern blotting analysis, the expression of unprenylated and
prenylated forms of Ras, a pivotal regulator of cell prolifer-
ation. As shown in Figure 6, in human SMCs cultured on
fibrillar collagen a significant accumulation of unprenylated
form of Ras was observed. As expected, similar results were
obtained with simvastatin.32
Discussion
In the present study we showed, for the first time, that
adhesion of human aortic SMCs on fibrillar collagen strongly
impaired cholesterol biosynthesis, the major end-point prod-
uct of the MVA pathway. Because the HMG-CoA reductase
is the rate limiting step of the MVA pathway,13 we focused
our attention on this enzyme by determining the effect of
fibrillar collagen at four different levels: the promoter activ-
ity, the mRNA and protein expression, and the enzyme
activity. All these parameters were significantly inhibited by
fibrillar collagen, indicating that the observed reduction of
cholesterol biosynthesis was indeed the result of reduced
HMG-CoA reductase activity. A direct demonstration that the
activity of this enzyme was affected by fibrillar collagen was
then provided by the fact that the incorporation of radiola-
beled MVA, the product of HMG-CoA reductase reaction,
into cellular cholesterol was not affected. Together with the
HMG-CoA reductase we also found a significant reduction of
the expression of the HMG-CoA synthase mRNA level,
indicating that both enzymes contributed to the inhibition of
the cholesterol biosynthesis in SMCs cultured on fibrillar
collagen.
Many of the mRNAs encoding enzymes involved in
cholesterol and FA synthesis are coordinately regulated by
the SREBP family of membrane-bound transcription fac-
tors.26,28 We therefore determined whether SREBPs were
involved in the regulation of HMG-CoA reductase expression
by fibrillar collagen. We observed that SREBP1a, but not
SREBP2, was differentially processed in cells cultured on
fibrillar versus monomer collagen. In particular, we observed
a consistent reduction of the active SREBP1a cleaved product
in human SMCs cultured on fibrillar collagen and a minor
reduction of the pro form of SREBP1a. In association with
these changes the inhibition of SREBP1a transcriptional
activity was demonstrated by the fact that the HMG-CoA
reductase promoter activity and the mRNA expression levels
of two genes directly regulated by SREBP1a (ie, FA-synthase
and HMG-CoA synthase27,28) were reduced in SMCs cultured
on fibrillar collagen.
The direct relationship between SREB1a transcriptional
activity and the expression of HMG-CoA reductase was also
demonstrated by the fact that the exogenous overexpression
of the active form of SREBP1a almost completely prevented
the effect of fibrillar collagen on HMG-CoA reductase levels
at the protein and mRNA levels. Moreover, a partial reduc-
tion of SREBP1a levels by siRNA significantly reduced the
expression of HMG-CoA reductase mRNA.
Although we clearly demonstrated a reduction of
SREBP1a transcriptional activity in SMCs on fibrillar colla-
gen, the molecular mechanism governing this event still
needs to be determined. The fact that the mRNA levels of
SREBP1a was reduced, but not in a statistically significant
manner, in response to fibrillar collagen indicates that the
regulation of SREBP1a may partially occur at the transcrip-
tional levels, but additional posttranscriptional regulation
mechanisms cannot be excluded. Further experiments will be
carried out to determine the effect of fibrillar collagen on
SREBP transport from ER to the Golgi, a very complex event
regulated by several factors, such as SCAP, Site-1, and Site-2
protease, and Insig1 and Insig2.26,33
The activation of SREBPs is a tightly regulated process
that responds primarily by the intracellular concentrations
of sterols.19 In the present study all the experiments were
performed in serum-free media, a condition that induces
the cholesterol neosynthesis by the activation of SREBP1a
and SREBP2.19,34 Under these conditions we did not
observe any significant change of total intracellular cho-
lesterol content, suggesting a specific role of fibrillar
collagen in the regulation of SREBP1a-dependent HMG-
CoA reductase expression. The lack of reduction in total
cholesterol content was expected for at least 3 reasons: (1)
the incubation time used was relatively short (48 hours),
Figure 6. Fibrillar collagen reduced Ras farnesylation in human
SMCs. Total cell lysates were prepared from human SMCs cul-
tured on monomer and fibrillar collagen for 48 hours in DMEM
containing 0.2% BSA. As a control, total protein extract was
prepared from human SMCs incubated with 5 mol/L simvasta-
tin. Ras prenylation was evaluated by Western blotting analysis
with a specific antibody anti-Ras. The slower migrating band
represents the unprenylated form of Ras (unpren. Ras), whereas
the faster migrating band is prenylated Ras (pren. Ras). Lower
panel, Quantitative densitometric analysis of prenylated and
unprenylated Ras was performed with Gel Doc acquisition sys-
tem Quantity One software (BIO-RAD) from films of 3 indepen-
dent experiments.
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(2) the cultured media used was free of cholesterol
acceptors (ie, HDL), and (3) the cells were in a quiescent
state under both cultured conditions.6,7 Moreover, our
observation is in agreement with pioneer experiments
conducted by Maltese et al35 in which the suppression of
cholesterol biosynthesis by 25-hydroxycholesterol in C-6
glioma cells incubated with serum free media for 48 hours
did not affect the sterol/protein ratio.
The interaction of human SMCs to collagen is primarily
mediated by 11 and 21 integrin receptors. By gene
array analysis we confirmed a previous observation that
fibrillar collagen specifically induces 2 and 1 integrin
subunit in human SMCs.3,18 By using blocking antibodies to
1 and 2 integrin subunits we then demonstrated that the
21 integrin receptor is at least partially involved in the
suppression of HMG-CoA reductase mediated by fibrillar
collagen, whereas 11 had no effect. These data indicate
that other collagen receptors may be involved in this cellular
response, including the recently discovered Discoidin domain
receptors (DDRs).29,36
Importantly, cell signal transduction events initiated by
cell adhesion to the ECM trough integrins are profoundly
regulated by the presence of cholesterol within the plasma
membrane lipid rafts.11,12 Indeed, disruption of lipid rafts
by cholesterol depletion mimicked loss of cell adhesion,
preventing targeting of prenylated protein Rac to the
plasma membrane and its coupling with downstream ef-
fector molecules.11,37 Reports from Pozo et al and Palazzo
at al also indicate that lipid rafts are commandeered by
integrins to target Rho and Rac to the cell membrane.11,12
Thus, integrin-mediated adhesion to ECM appears to be
directly involved in lipid raft assembly. Moreover, an
elegant study conducted in 1 null fibroblast cell line
demonstrated that cell adhesion through 1 integrin recep-
tor regulates the amount of cholesterol present in the lipid
raft without altering the total intracellular cholesterol
levels.38 Our study further implements these observations
demonstrating, for the first time, that signaling from
integrin receptors regulates cholesterol biosynthesis by
altering the activity of HMG-CoA reductase. Moreover,
we demonstrated that the inhibition of HMG-CoA reduc-
tase and therefore the MVA pathway affected protein
prenylation of Ras. On this matter it is tempting to
speculate that the inhibition of Ras prenylation, and
therefore its function, may contribute to the G1 arrest of
the cell cycle described in human SMCs cultured on
fibrillar collagen.7
The effect of fibrillar collagen on SMC proliferation has
been previously interpreted to being relevant in maintaining
SMCs in a low proliferative index in normal media, whereas
in response to proteolytic enzymes, the degradation of colla-
gen may alter the cellular response to growth factors facili-
tating the accumulation of SMCs within the atherosclerotic
plaque.6,7 Our findings further implement this hypothesis
demonstrating that the suppression of the MVA pathway and
protein prenylation may be one of the basic molecular events
implicated in the maintenance of SMCs in a quiescent state
and preventing their accumulation in the neointimal during
atherogenesis.
In association with cell cycle arrest Koyama et al have
described a reduction of focal adhesion sites and actin stress
fibers formation in SMCs cultured on fibrillar collagen.7
These effects may be indicative of a deregulation of the
prenylated proteins Rho, Rac, and Cdc42, potentially related
to the reduced activity of HMG-CoA reductase and therefore
protein prenylation.39 Further studies will be aimed at inves-
tigating the effect of fibrillar collagen on Rho protein func-
tion as related to cell morphology and plasma lipid rafts
formation.
In conclusion, our study adds new insights in the
complexity of the regulation of cholesterol homeostasis,
revealing the 21 integrin-dependent effect of fibrillar
collagen on HMG-CoA reductase expression and synthesis
of MVA-derived isoprenoids involved in protein prenyla-
tion processes. Type I fibrillar collagen-dependent regula-
tion of HMG-CoA reductase expression reported here
could perhaps be informative in understanding the basic
molecular mechanisms that regulate SMC accumulation in
atherosclerotic plaque but also for the development of
dyslipidemia in patients affected by liver fibrosis where
deposition of fibrillar collagen is observed.40,41
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